HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel E Johnson Selected Research

octa-2,4,6-trienoic acid

9/2003Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor autocrine signaling in head and neck squamous carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel E Johnson Research Topics

Disease

47Neoplasms (Cancer)
01/2022 - 07/2002
43Squamous Cell Carcinoma of Head and Neck
01/2022 - 04/2003
20Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 04/2003
5Carcinogenesis
01/2020 - 08/2012
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 09/2003
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2018 - 12/2007
3Leukemia
07/2015 - 01/2005
2Mouth Neoplasms (Oral Cancer)
08/2016 - 07/2016
2Multiple Myeloma
02/2015 - 12/2012
2Prostatic Neoplasms (Prostate Cancer)
06/2006 - 07/2004
1Bites and Stings (Sting)
10/2021
1Stroke (Strokes)
02/2021
1Laryngeal Neoplasms (Laryngeal Cancer)
11/2020
1Rheumatoid Arthritis
01/2020
1Myeloproliferative Disorders (Myeloproliferative Disorder)
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2019
1Pharyngeal Neoplasms
06/2017
1Papillomavirus Infections
06/2017

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
11/2021 - 11/2004
10Cetuximab (Erbitux)FDA Link
11/2021 - 11/2009
8Biomarkers (Surrogate Marker)IBA
10/2021 - 08/2016
7ErbB Receptors (EGF Receptor)IBA
01/2022 - 09/2003
7Proteasome InhibitorsIBA
02/2015 - 06/2008
6Bortezomib (Velcade)FDA Link
02/2015 - 06/2008
5Cisplatin (Platino)FDA LinkGeneric
11/2021 - 06/2008
5OligonucleotidesIBA
01/2020 - 04/2003
5STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
10/2019 - 04/2003
4Pharmaceutical PreparationsIBA
10/2021 - 05/2005
4Caspase 8 (Caspase-8)IBA
01/2021 - 10/2014
4carfilzomibIBA
02/2015 - 10/2012
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2022 - 01/2019
3Tyrosine Kinase InhibitorsIBA
11/2021 - 01/2017
3Immune Checkpoint InhibitorsIBA
10/2021 - 12/2018
3RNA (Ribonucleic Acid)IBA
02/2021 - 03/2013
3Monoclonal AntibodiesIBA
11/2020 - 01/2017
3Transcription Factors (Transcription Factor)IBA
01/2020 - 04/2003
3sulforaphaneIBA
12/2019 - 06/2006
3Tyrosine (L-Tyrosine)FDA Link
01/2019 - 01/2016
3Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2018 - 12/2007
3Oncogene Proteins (Oncogene Protein)IBA
01/2018 - 07/2002
3Biological ProductsIBA
06/2015 - 05/2009
3ONX 0912IBA
09/2014 - 10/2012
2Messenger RNA (mRNA)IBA
10/2021 - 01/2016
2CytokinesIBA
01/2021 - 01/2020
2Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2018
2Phosphotransferases (Kinase)IBA
01/2020 - 01/2019
2NucleotidesIBA
01/2020 - 10/2019
2Death Domain ReceptorsIBA
01/2018 - 10/2014
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2017 - 11/2009
2CarcinogensIBA
08/2016 - 07/2016
2Proteasome Endopeptidase Complex (Proteasome)IBA
02/2015 - 03/2013
2Annexin A5IBA
02/2014 - 10/2007
2pregna-4,17-diene-3,16-dione (guggulsterone)IBA
11/2009 - 08/2009
2Peptides (Polypeptides)IBA
05/2009 - 10/2007
2Etoposide (VP 16)FDA LinkGeneric
05/2009 - 05/2005
2Cytochromes c (Cytochrome c)IBA
10/2007 - 06/2006
1AlpelisibIBA
11/2021
1Immune Checkpoint ProteinsIBA
11/2021
1Fibronectins (Fibronectin)IBA
10/2021
1Caveolin 1IBA
10/2021
1Protein Isoforms (Isoforms)IBA
10/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2021
1Cytotoxins (Cytolysins)IBA
10/2021
1Mutant Proteins (Protein, Mutant)IBA
10/2021
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
10/2021
1Protein Kinases (Protein Kinase)IBA
10/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2021
1Deubiquitinating EnzymesIBA
01/2021
1Lysine (L-Lysine)FDA Link
01/2021
1Doxycycline (Periostat)FDA LinkGeneric
01/2021
1EnzymesIBA
01/2021
1pembrolizumabIBA
11/2020
1NivolumabIBA
11/2020
1Janus Kinase InhibitorsIBA
01/2020
1Dinoprostone (PGE2)FDA Link
01/2020
1Glycogen Synthase Kinase 3IBA
01/2020
1Therapeutic UsesIBA
01/2020
1Janus KinasesIBA
01/2020
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020
1LigandsIBA
12/2019
1ceralasertibIBA
01/2019
1Agent MIBA
01/2019
1src-Family KinasesIBA
11/2018
1Dasatinib (BMS 354825)FDA Link
11/2018
1Cell Surface ReceptorsIBA
01/2018
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2018
1Chimeric Antigen ReceptorsIBA
01/2018
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2017
1nimotuzumabIBA
01/2017

Therapy/Procedure

23Therapeutics
10/2021 - 01/2005
9Drug Therapy (Chemotherapy)
11/2020 - 07/2002
4Chemoprevention
12/2019 - 06/2015
2Radiotherapy
10/2021 - 07/2002
2Precision Medicine
01/2020 - 12/2018
2Immunotherapy
12/2018 - 01/2018
1Toothbrushing
02/2021
1Chemoradiotherapy
11/2020
1Microbubbles
01/2020